- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02399488
Validation of Continuous Noninvasive Haemoglobin Monitoring by the Radical 7 Pulse CO-Oximetry Monitor After in Vivo Adjustment.
Validation of a Continuous Noninvasive Haemoglobin Determination Monitor (Radical 7 Pulse CO-Oximeter, SpHb) Compared to the Central Laboratory Coulter (LabHb) and a Point of Care (POC) Invasive Cooximeter (COoxHb) After in Vivo Adjustment.
Continuous haemoglobin determination could improve the outcomes of several patients in risk of bleeding during surgery. An in vivo calibration has been introduced to the device after our team found its need. The uncalilbrated validation of the Masimo Radical 7 continuous haemoglobin monitor has been made in various papers, although it has been compared to point of care devices, thus introducing an error as such point of care devices although validated for haemoglobin determination, are not as accurate as the gold standard. The validation of the gold standard calibrated device has not been described yet.
When compared to the accepted gold standard (cyanmethemoglobin method, Coulter), accuracy and precision of the continuous haemoglobin monitor could be good enough to be used interchangeably with the gold standard.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Continuous haemoglobin determination could improve the outcomes of several patients in risk of bleeding during surgery.
The in vivo calibration has not been adjusted to the gold standard haemoglobin determination in the literature yet.
Two blood samples will be withdrawn at the same time from an arterial line, one for the central laboratory and the other one for the POC device. At the same exact time the SpHb measurement will be recorded. At least eight samples are expected per patient. A maximum of 20 samples will be withdrawn per patient.
To compare bias, precision and limits of agreement among SpHb, LabHb and COoxHb the Bland Altman method will be used with multiple observations per subject when the true value varies. An error grid analysis will be made to know how it could affect to clinical decision making.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46023
- Recruiting
- University Hospital Doctor Peset
-
Contact:
- Juan Soliveres, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients.
- Surgery duration of at least two hours.
- Patients scheduled to surgery under general anaesthesia and muscle relaxation.
- Radial arterial line needed for blood pressure control or other reason not related to the study.
Exclusion Criteria:
- Radial arterial line not indicated / not possible to place.
- Sampling difficult or impossible.
- Need to reposition arterial line arm during surgery.
- Any illness that could influence the haemoglobin measurement.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Central coulter bias and limits of agreement
Time Frame: 3 months
|
Bias and limits of agreement of SpHb compared to the central laboratory coulter
|
3 months
|
Central coulter bias and limits of agreement after in vivo calibration
Time Frame: 3 months
|
Bias and limits of agreement of SpHb compared to the central laboratory coulter after in vivo Radical 7 calibration
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
POC Cooximeter bias and limits of agreement
Time Frame: 3 months
|
Bias and limits of agreement of SpHb compared to the POC cooximeter
|
3 months
|
POC Cooximeter bias and limits of agreement
Time Frame: 3 months
|
Bias and limits of agreement compared to the POC cooximeter after in vivo Radical 7 calibration
|
3 months
|
POC Cooximeter Coulter interchangeability
Time Frame: 3 months
|
Bias and limits of agreement of POC Cooximeter Hb determination compared to the central laboratory coulter
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of bias and limits of agreement
Time Frame: 3 months
|
Comparison of bias and limits of agreement among central laboratory, POC cooximeter and SpHb continuous monitor.
|
3 months
|
Clinical decision making
Time Frame: 3 months
|
Error grid analysis plot
|
3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Juan Soliveres, MD, PhD, University Hospital Doctor Peset
Publications and helpful links
General Publications
- Soliveres J, Balaguer J, Estruch M, Sánchez A, Sánchez J. Validation of Continuous and Noninvasive Hemoglobin Monitoring from Pulse CO-Oximetry during Surgery. 2010 Annual Meeting of the American Society Anesthesiologists
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CEIC:47/10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sphb Haemoglobin in Vivo Validation
-
Terumo BCTCompletedDevice Validation of In-vivo PerformanceUnited States
-
Central South UniversityCompletedFocus of Study: Pharmacokinetics Analysis, in Vivo Dissolution Studies
-
Fondazione Don Carlo Gnocchi OnlusGöteborg UniversityUnknownValidation Fugl-Meyer Scale in Italian
-
Asan Medical CenterCompletedValidation of In-vitro Turbidometric Platelet Aggregation Assay
-
National Taiwan University HospitalRecruiting
-
GE HealthcareCompletedGather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd TrimesterUnited States
-
Meshalkin Research Institute of Pathology of CirculationNot yet recruitingthe Strength Properties of the Aorta in Vivo | the Strength Properties of the Aorta in Vitro | Regression Model of Aortic Strength Properties in Vitro and in VitroRussian Federation
-
State University of New York - Upstate Medical...WithdrawnAssess Motion in Flexion/Extension and Lateral Bending of the Lumbar Vertebrae in Vivo Following Motion Sparing Surgery Using Radiostereometric Analysis (RSA.)United States
-
Fondazione Don Carlo Gnocchi OnlusGöteborg UniversityUnknownValidation Fugl Meyer Scale in ItalianItaly
-
Medical University InnsbruckUnknownValidation of Kujala Score German Version in Patients With Patellofemoral Instability and Scheduled MPFL-reconstructionAustria
Clinical Trials on Masimo Radical 7
-
Pamela PetersenCompleted
-
Manisa Celal Bayar UniversityCompleted
-
Trakya UniversityCompletedPerfusion Index | One-Lung Ventilation | Hypoxemia During Surgery | Oxygen Reserve Index | Pleth Variability IndexTurkey
-
Cedars-Sinai Medical CenterMasimo CorporationTerminatedMajor Spine Surgery ProcedureUnited States
-
Baskent University Ankara HospitalCompletedHyperoxia | Oxygen Reserve Index | Hyperoxemia | Fraction of Inspired OxygenTurkey
-
Samsun Education and Research HospitalCompleted
-
George Washington UniversityActive, not recruiting
-
Antalya Training and Research HospitalCompletedCesarean Section ComplicationsTurkey
-
Città di Roma HospitalUnknownDelivery UterineItaly
-
Kasr El Aini HospitalUnknownAntepartum Hemorrhage